| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 04/15/2010 | US20100092990 Nucleic acids encoding sodium channel scn1a alpha subunit proteins and mutations associated with epilepsy |
| 04/15/2010 | US20100092557 Dosage Form Comprising Immediate Release Naproxen and Sustained Release Opioid Analgesic |
| 04/15/2010 | US20100092545 Polyethylene-oxide based films and drug delivery systems made therefrom |
| 04/15/2010 | US20100092507 Purified component of blue-green algae and method of use |
| 04/15/2010 | US20100092488 Method for Treatment or Prevention of Disease Associated Wtih Functional Disorder of Regulatory T Cell |
| 04/15/2010 | US20100092486 Modulation of myeloid differentation primary response gene 88 (myd88) expression by antisense oligonucleotides |
| 04/15/2010 | US20100092472 Compounds and methods for the modulation of beta-1 integrin function to mediate tissue repair |
| 04/15/2010 | US20100092469 Antagonists of a non-selective cation channel in neural cells |
| 04/15/2010 | US20100092444 Platelet rich plasma formulations for cardiac treatments |
| 04/15/2010 | US20100092436 Compositions and methods for restoring immune responsiveness in patients with immunological defects |
| 04/15/2010 | US20100092425 Nicotine Immunonanotherapeutics |
| 04/15/2010 | US20100092403 aerosol sprays; fast onset of effect |
| 04/15/2010 | US20100092385 Novel Heteroaryl Substituted Imidazo [1,2-A] Pyridine Derivatives |
| 04/15/2010 | DE4315525B4 Pharmazeutische Zusammensetzung Pharmaceutical composition |
| 04/15/2010 | CA2776945A1 Methods and compositions for treating status epilepticus and seizures causing status epilepticus |
| 04/15/2010 | CA2755968A1 Substituted 3-arylsulfonyl-pyrazolo[1,5-a]pyrimidines, serotonin 5-ht6 receptor antagonists and methods for the production and use thereof |
| 04/15/2010 | CA2740087A1 Gaba conjugates and methods of use thereof |
| 04/15/2010 | CA2740003A1 Pyrone analogs for therapeutic treatment |
| 04/15/2010 | CA2739877A1 The 1-butyl-2-hydroxyaralkyl piperazine derivatives and the uses as anti-depression medicine thereof |
| 04/15/2010 | CA2739787A1 .beta.-hydroxy-.gamma.-aminophosphonates and methods for the preparation and use thereof |
| 04/15/2010 | CA2739559A1 Tetrahydrofuranyl sulfonamides and pharmaceutical compositions thereof |
| 04/15/2010 | CA2736924A1 Modulators for amyloid beta |
| 04/14/2010 | EP2174955A1 Ifnar2 muteins, their production and use |
| 04/14/2010 | EP2174954A1 Hematopoietic cell e-selection/l-selectin ligand polypeptides and methods of use thereof |
| 04/14/2010 | EP2174949A2 Leucine-based motif and clostridial neurotoxins |
| 04/14/2010 | EP2174940A1 Process for production of optically active mirtazapine |
| 04/14/2010 | EP2174939A1 Pyranones useful as ATM inhibitors |
| 04/14/2010 | EP2174666A1 Medicinal agent for prevention or treatment of alzheimer's disease |
| 04/14/2010 | EP2174661A1 Agent for improving dysfunction due to neuropathy and rho kinase activation inhibitor |
| 04/14/2010 | EP2174659A1 Substituted indeno[1,2-c]isoquinoline derivatives and uses thereof |
| 04/14/2010 | EP2173766A1 Process for the preparation glatiramer acetate (copolymer-1) |
| 04/14/2010 | EP2173743A2 Sodium channel inhibitors |
| 04/14/2010 | EP2173733A2 Compositions and methods comprising analogues of radicicol a |
| 04/14/2010 | EP2173720A2 2-imidazolines having a good affinity to the trace amine associated receptors (taars) |
| 04/14/2010 | EP2173719A1 4-imidazolines and their use as antidepressants |
| 04/14/2010 | EP2173369A2 Novel method for screening brain-active compounds |
| 04/14/2010 | EP2173366A2 Medicament for treating parkinson's disease |
| 04/14/2010 | EP2173365A2 Medicament for treating parkinson's disease |
| 04/14/2010 | EP2173355A2 Pirenzepine and derivatives thereof as anti-amyloid agents |
| 04/14/2010 | EP2173345A2 A method for decreasing symptoms of alcohol consumption |
| 04/14/2010 | EP2173344A1 Treatment or prophylaxis or neurological or neuropsychiatric disorders via ocular administration |
| 04/14/2010 | EP2173340A1 Methods of enhancing cognitive function using non-peptidic compounds |
| 04/14/2010 | EP2173170A2 Fused heterocycles |
| 04/14/2010 | EP1919869B1 Indole derivatives as ppar activators |
| 04/14/2010 | EP1809273B1 Use of 2-phenyl-1,2-ethanediol-(di)carbamates for treating epileptogenesis |
| 04/14/2010 | EP1796678B1 Carboxamide spirolactam cgrp receptor antagonists |
| 04/14/2010 | EP1663229B1 Pharmaceutical combinations of hydrocodone and naltrexone |
| 04/14/2010 | EP1656141B1 Treatment for alzheimer s disease and related conditions |
| 04/14/2010 | EP1627871B1 Cyclic aminophenyl sulfamate derivative |
| 04/14/2010 | EP1551799B1 Cyclohexyl sulphones as gamma-secretase inhibitors |
| 04/14/2010 | EP1477482B1 Novel phenylalanine derivative |
| 04/14/2010 | CN1968694B An analgesic pharmaceutical composition |
| 04/14/2010 | CN1935230B Chinese medicine injection preparation and its preparing method |
| 04/14/2010 | CN1911211B Solid oral preparation of leishajilan |
| 04/14/2010 | CN1891300B Benzocaine film-formed gel composition and its use |
| 04/14/2010 | CN1778296B Long-acting preparation for tatin medicine |
| 04/14/2010 | CN1739655B Quality control method of Qingkailing injection preparation |
| 04/14/2010 | CN1607950B A liquid pharmaceutical formulation comprising nicotine for the administration to the oral cavity |
| 04/14/2010 | CN101693865A Mulberry leaf pure wine and production process thereof |
| 04/14/2010 | CN101693740A Homerl protein and application thereof in treating or preventing cerebral injury disease |
| 04/14/2010 | CN101693714A spirocyclic cyclohexane derivatives |
| 04/14/2010 | CN101693711A 3-(1-piperazinyl)-1,2-benzisothiazole derivative as well as synthesizing method and application thereof |
| 04/14/2010 | CN101693689A New method for extracting and separating high-purity huperzine A from thousand-layer column |
| 04/14/2010 | CN101693113A Divalproex sodium medicine composition with improved oral absorptivity |
| 04/14/2010 | CN101693107A Methods of treating neurological conditions with hematopoeitic growth factors |
| 04/14/2010 | CN101693023A Transparent transdermal nicotine delivery device |
| 04/14/2010 | CN101693017A Medicament composition of levetiracetam and preparation process |
| 04/14/2010 | CN101234121B Application of purslane amide alkaloid in preparing antioxidant and neuroprotective agent |
| 04/14/2010 | CN101152458B Traditional Chinese medicine preparation for treating cerebral apoplexy sequela |
| 04/14/2010 | CN101129353B Use of 7-hydroxyl-3-[(4-hydroxyl)-3-(3-methyl- butyl-2- alkenyl) phenyl]-4H-1-benzopyran-4-ket |
| 04/14/2010 | CN101002879B Application of timosaponin for preparing medicine treating anxiety disorders |
| 04/14/2010 | CN100998733B Oral traditional Chinese medicine for treating trigeminal neuralgia of prolonged illness entering subsidiary channels type |
| 04/13/2010 | US7696234 Histamine H3 receptor agents, preparation and therapeutic uses |
| 04/13/2010 | US7696209 1(R)-1-(4-methyl-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-2-oxo-2-[4-(tetrahydropyran-4-yl)-piperazin-1-yl]-ethyl 4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl); calcitonin gene related peptide antagonist; analgesic, antidiabetic agent; migraine or cluster headaches, non-insulin-dependent diabetes |
| 04/13/2010 | US7696207 Therapeutic agents useful for treating pain |
| 04/13/2010 | US7696198 Phosphodiesterase 4 inhibitors |
| 04/13/2010 | US7696196 (R)-1-(3,4-dibromo-benzyl)-2-[4-(1-methyl-piperidin-4-yl)-piperazin-1-yl]-2-oxo-ethyl4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidine-1-carboxylate, for example; treatment of headaches, particularly migraine or cluster headaches |
| 04/13/2010 | US7696194 Visual function disorder improving agents |
| 04/13/2010 | US7696193 Such as 6-(3-cyclobutyl-2,3,4,5-tetrahydro-1H-benzo[d]azepin-7-yloxy)-N-methyl-nicotinamide; for treatment of neurological and psychiatric disorders |
| 04/13/2010 | US7696181 Partial and full agonists of A1 adenosine receptors |
| 04/13/2010 | US7696172 culture product produced by culturing a recombinant host cell under suitable conditions to express the polypeptide; has an oncogenic activity; treating liver disorder cirrhosis, or pancreas disorder |
| 04/13/2010 | US7696157 Plurality of isolated erythropoietin-like molecules; reperfusion injuries; antiischemic, antihypoxic, antiinflammatory gents; neurodegenerative or nervous system disorders; genetic engineering and expression |
| 04/13/2010 | US7696156 Human hemojuvelin (HJV) or dragon-like 1 (DL-1) polypeptides and variants and uses thereof |
| 04/13/2010 | US7696155 Hemojuvelin or dragon-like 2 (DL-2) polypeptides and variants and uses thereof |
| 04/13/2010 | US7695903 diagnosing Alzheimer's disease by measuring abundance of low-density lipoprotein receptor related protein-1 (LRP-1), abundance of transcripts thereof, or LRP-1 receptor activity and comparing with an age-matched control |
| 04/13/2010 | US7695723 Methods of treating neurological conditions with hematopoietic growth factors |
| 04/13/2010 | CA2549752C 1-benzyl-4-[(5,6-dimethoxy-1-indanone)-2-yl] methyl piperidine oxalate (donepezil oxalate) and its polymorphs |
| 04/13/2010 | CA2474219C Dihydrobenzodiazepin-2-one derivatives iii |
| 04/13/2010 | CA2443802C Pyrazolo[1,5-a]pyridines and medicines containing the same |
| 04/13/2010 | CA2432303C Pyrazole compounds useful as protein kinase inhibitors |
| 04/13/2010 | CA2430363C Compounds and their uses |
| 04/13/2010 | CA2422377C Pyrazole compounds useful as protein kinase inhibitors |
| 04/13/2010 | CA2418848C Cng2b: a novel human cyclic nucleotide-gated ion channel |
| 04/13/2010 | CA2407683C Topical anesthetic/opioid formulations and uses thereof |
| 04/13/2010 | CA2399208C Nucleoside analogs with carboxamidine modified monocyclic base |
| 04/13/2010 | CA2394229C Loci for idiopathic generalized epilepsy, mutations thereof and method using same to assess, diagnose, prognose or treat epilepsy |
| 04/13/2010 | CA2394165C Drospirenone for hormone replacement therapy |
| 04/13/2010 | CA2374997C Il6ril6 chimera for the treatment of neurodegenerative diseases |
| 04/13/2010 | CA2373634C Isophosphoramide mustard analogs and use thereof |
| 04/13/2010 | CA2360680C Antioxidant compositions and methods for companion animals |